Unsurprisingly, lower blood cell Pentraxin 3 (PTX3) promoter DNA methylation levels were associated with higher PTX3 plasma levels and also neutrophil:lymphocyte ratio and presence of coronary artery disease. Here, PTX3 is linked to coronary artery disorder.